MyLeukemiaTeam

Does Pegasys (pegylated interferon alfa-2a) cause liver damage?

Pegasys is a type of interferon (IFN) therapy used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL). It works by slowing the growth of cancer cells and helping the immune system attack them.

Pegasys Show Full Answer

Does Pegasys (pegylated interferon alfa-2a) cause liver damage?

Pegasys is a type of interferon (IFN) therapy used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and hairy cell leukemia (HCL). It works by slowing the growth of cancer cells and helping the immune system attack them.

Pegasys can cause side effects, and liver-related effects are something to be aware of. Here are some key points:

- Pegasys is a pegylated form of interferon, meaning it's been chemically modified to stay in the blood longer
- This allows for lower doses, which generally means fewer and more manageable side effects
- However, like many leukemia treatments, it can still affect liver enzyme levels, so doctors typically monitor liver function regularly during treatment

It's really important to discuss any concerns about liver health directly with your oncologist or hematologist. They can monitor your liver function through blood tests and adjust your treatment if needed.

Never stop or adjust Pegasys on your own — always consult your care team first.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Interferon Therapy for Leukemia: When Is It Used?